Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phentolamine Mesylate Eye Drops for Reversal of Drug-Induced Mydriasis in Healthy Participants
CTR20254757Phase 3Active
- Sponsor
- Shifangji Pharmaceutical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of phentolamine in iatrogenic mydriasis, sponsored by Shifangji Pharmaceutical. Started Dec 2025; status: active.
02
Drugs
phentolamine
03
Conditions
iatrogenic mydriasis
Beyond the preview
Go deeper on CTR20254757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254757.